Hence, we decided to investigate the impact of knocking down TOMM20 using CRISPR‐Cas9 in sarcoma cell lines and evaluate whether TOMM20 is essential for the expression of drivers of cancer aggressiveness (Fig. 5A; Fig. S6A). This evidence concerns the gene TOMM20 and sarcoma.